1997
DOI: 10.1016/s0006-8993(97)00290-4
|View full text |Cite
|
Sign up to set email alerts
|

Amyloid precursor protein accumulates in white matter at the margin of a focal ischaemic lesion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
45
1
2

Year Published

2001
2001
2012
2012

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 83 publications
(52 citation statements)
references
References 38 publications
4
45
1
2
Order By: Relevance
“…Pathological amyloid precursor protein staining especially for -amyloid peptide and C-terminal has been observed in periventricular and subcortical white matter after ischemic brain injury . The more intense postischemic brain injury of white matter is, the more extensive is the staining of different parts of amyloid precursor protein in this region (Yam et al, 1997). In contrast, in our unpublished studies, the data are opposite.…”
Section: Amyloid Precursor Protein and β-Amyloid Peptide After Ischemiacontrasting
confidence: 59%
“…Pathological amyloid precursor protein staining especially for -amyloid peptide and C-terminal has been observed in periventricular and subcortical white matter after ischemic brain injury . The more intense postischemic brain injury of white matter is, the more extensive is the staining of different parts of amyloid precursor protein in this region (Yam et al, 1997). In contrast, in our unpublished studies, the data are opposite.…”
Section: Amyloid Precursor Protein and β-Amyloid Peptide After Ischemiacontrasting
confidence: 59%
“…Therefore, the SMI-32 antibody can be used to detect axonal injury under many conditions (Gresle et al, 2006). Although many authors have detected axonal injury by amyloid precursor protein immunohistochemistry, assessment of axonal injury with an amyloid precursor protein antibody is limited, because the immunostaining is restricted mainly to the margins of the ischemic lesion, and hence is largely absent from the ischemic core (Gresle et al, 2006;Yam et al, 1997). Therefore, we used SMI-32 immunohistochemistry, and clearly detected axonal injury.…”
Section: Fig 7 (A and B)mentioning
confidence: 99%
“…White matter injury was evaluated only by immunostaining, which is difficult to quantify. Some authors have evaluated white matter injury after focal ischemia using an amyloid precursor protein immunoreactivity score (Imai et al, 2001;Yam et al, 1997); however, such scoring systems are not quantitative. We need to develop a quantitative evaluating method in a future study.…”
Section: Fig 7 (A and B)mentioning
confidence: 99%
“…Oligodendrocytes are the most vulnerable glial cell, followed by microglia and then astrocytes, to combined glucose and oxygen deprivation in vitro (Lyons and Kettenmann, 1998;McDonald et al, 1998). Global and focal ischemia can damage white matter (Kurumatani et al, 1998;Pantoni et al, 1996;Valeriani et al, 2000;Yam et al, 1997). Death of oligodendrocytes has been documented at the margins of the infarct and some of the dying oligodendrocytes are TUNEL positive (Mandai et al, 1997).…”
Section: White Matter Injury Can Stimulate Microglial/macrophage Prolmentioning
confidence: 99%